INSPECS Group plc (AIM:SPEC)
London · Delayed Price · Currency is GBP · Price in GBX 89.65
-0.35 (-0.39%)
Oct 9, 2026, 12:17 PM GMT
INSPECS Group Market Cap
INSPECS Group has a market cap or net worth of 98.26 million as of October 9, 2026. It is the 23,659th most valuable company in the world and the 513th biggest in the United Kingdom. Its market cap has increased by 103.46% in one year.
Market Cap
98.26M
Enterprise Value
127.17M
Revenue
193.23M
Global Rank
Country Rank
#513 United Kingdom
PE Ratio
n/a
ChartMarket Cap Chart
Since February 27, 2020, INSPECS Group's market cap has decreased from 137.95M to 98.26M, a decrease of -28.78%. That is a compound annual growth rate of -5.00%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 98.26M | 35.16% |
| Dec 31, 2025 | 72.70M | 57.14% |
| Dec 31, 2024 | 46.26M | -45.83% |
| Dec 29, 2023 | 85.40M | 95.35% |
| Dec 30, 2022 | 43.72M | -88.33% |
| Dec 31, 2021 | 374.78M | 12.12% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Feb 27, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 186.09B |
| GSK plc | 70.12B |
| Haleon | 30.76B |
| Smith & Nephew | 8.58B |
| AOTI, Inc. | 140.93M |
| Scancell Holdings | 112.74M |
| EKF Diagnostics Holdings | 111.34M |
| Bioventix | 95.35M |